What is an ultrasound of fibroid?
Fibroid ultrasound is a diagnostic tool usually used to locate or treat uterine fibroid tumors, also called leiomyomas or fibroids. Uterine fibroids are non -lawn tumors that grow in the muscle tissue of the uterus. It is estimated that between 20 and 50 percent of women in their fertile years have uterine fibroids. Some women do not experience any symptoms, but if the tumor is large, or if more tumors are growing inside the uterine walls, the most common symptoms include heavy and prolonged menstrual periods, pelvic pain or pressure and enlarged or inflated abdomen. The device is the same as to view the fetus during pregnancy. The probe is usually placed on the abdomen and high -intensity high -intensity waves are transmitted to provide a fibroid image on the bed monitor. In some cases, the vaginal probe may provide an improved picture -out outpatient procedure to treat uterine tumors. The treatment is non -invasive. Recovery time is usually shorter than after surgery such as Hysterectomy or fibroids.
During the procedure, ultrasonic (HIFU) waves focused on high intensity are emitted from the scanner for magnetic resonance imaging (MRI), usually destroying the tumor without affecting the uterine tissue surrounding the fibroid. High -energy waves heat a pulse tumor for about 15 seconds, which is then repeated about 50 times during the procedure. Most procedures may take up to 3 hours, depending on the size of the tumors and how many tumors are present.
The risks of adverse side effects from treatment were not calculated. The most common risks are burns, nerve damage and repetition of fibroid tumor. Other problems with fibroid ultrasound may include limited access to the procedure and a high price mark that does not have to apply to health insurance. Exblate is the only FDA approved by ultrasonic ultrasound led by the FDA available in the United States. InSietiec ltd that has developed exbaLTE, states that three published posts found that treatment is safe and effective for uterine fibroid tumors.